In June 2020, Zydus Cadila had received approval from Mexico's
regulatory authority Cofepris to test one of its lead research
candidate Desidustat in the management of COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/articleshow/80444749.cms
No comments:
Post a Comment